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Little is known about the antigen in rat kidney tissue which is responsible 
for the production of the nephrotoxic antibodies in  the serum of rabbits im- 
munized  with  suspensions  of  rat  kidney.  We  have  demonstrated  that  this 
antigen is not limited to the glomerulus, but is present in  cortical tissue from 
which  the glomeruli have been removed, in medullary  tissue which contains 
no glomeruli, and indeed in other organs (1). In addition, we have found that 
the antigen can be extracted to some extent with saline from rat kidney ho- 
mogenate. 
The question of solubility of the nephrotoxic serum antigen  1 is of obvious im- 
portance. Obtaining the antigen in soluble form is a prerequisite for studies on the 
nature of the antigen or a hapten which might be derived from it.  The insolubility 
of the antigen in saline has been emphasized  heretofore (2, 3) although Greenspon, 
Bollinger, and Krakower (4) described the extraction of soluble antigen from glomer- 
ular basement membranes.  Cole, Cromartie, and Watson (2) did not detect the antigen 
in saline extracts of kidney, but found that trypsin digestion  of kidney homogenate 
releases a substance into solution  which will neutralize nephrotoxic antibodies.  This 
latter finding has been confirmed by Pressman et al., (5) and us (6). Cole et al., (3) 
stated that preliminary results indicated that the soluble substance was not antigenic, 
suggesting that it might be a hapten split off from a whole kidney antigen. The present 
report describes the preparation, purification,  and some of the characteristics of this 
soluble factor presumably derived from the tissue antigen responsible for the produc- 
tion of nephrotoxic antibodies. 
We have used two methods to detect the presence of the antigen or antigen 
derivative in  simple  extracts or  the  supernatant  fluid from trypsin-digested 
tissue  homogenates.  The  ability  of  the  kidney  extracts  and  trypsin  digest 
supernatant  solutions  to  stimulate production of nephrotoxic antibodies was 
determined by immunizing rabbits with  these preparations and assaying the 
*  For the sake of brevity, the antigen capable of inducing the formation of nephrotoric 
antibodies will be referred to as the nephrotoxic serum antigen. 
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rabbit sera in rats for  the presence of nephrotoxic antibodies. In addition, all 
extracts  and tissue digest  supernatant fluids were  tested  for  ability to  absorb 
nephrotoxic antibodies from pooled antikidney serum; the nephrotoxicity of the 
absorbed antisera was measured in a  standard rat assay. The absorption pro- 
cedure will detect either whole antigen or a substance derived from it which can 
neutralize nephrotoxic sera. In discussing the results of the assays of absorbed 
antiserum, we refer to  the substance which absorbs nephrotoxic antibodies as 
having a  "protective"  effect.  This substance may be the whole  antigen, or it 
may  be  a  relatively non-antigenic derivative  which  we  refer  to  as  "soluble 
protective factor." 
Materials and Methods 
Produvtion of Standard Pooled Nephrotoxlv Serum.--Perfused  kidneys were obtained from 
0sborne-Mendel rats. Saline suspensions of kidney homogenate, or a fraction of kidney homo- 
genate containing concentrated glomeruli, were injected intraperitonealiy into New Zealand 
white adult male rabbits. Details of the technique and the testing and pooling of sera from 
these rabbits were described in the previous report (1). 
Trypsin  Digestion and Autolysis of Kidney Homogenate.--Thls procedure was carried out 
as described by Cole et al. (2). 90 gm. of perfused or unperfused whole kidneys (obtained from 
Osborne-Mendel rats) was minced and added to 90 ml. of 0.15 ~  saline at 2°C. and homog- 
euized for  2 minutes in a Waring blendor.  The homogenate was brought to pH 8.0 to 8.2 
(with 0.1 ~  borate buffer in early experiments, and 3 per cent NaOI-I in later experiments) 
and divided into two equal portions in separate beakers (beakers I and II). 164 rag. of trypsin  ~ 
was stirred into beaker I; nothing was added to beaker II; and both beakers were incubated 
at 37°C. for 3 hours. Each 30 minutes the pH of the trypsin digest in beaker I  and of the 
autolyzing kidney homogenate in beaker II was readjusted to pH 8.0 with 3 per cent NaOH. 
At the end of 3 hours, the contents of both beakers were heated to 60°C. for 30 minutes. Fol- 
lowing this, the contents were centrifuged at 65,900 G. (27,500 R.v.x{. in the No. 30 rotor of the 
Spinco ultracentrifuge) for 1 hour, and the clear tea-colored  supernatant fluid was drawn off 
for testing. The protein content of trypsin digest supernatant solutions and of fractions de- 
rived from them was determined by either the biuret method (7) or, after dialysis, by Kjehldahl 
nitrogen analysis, or by ultraviolet absorption at 280 m/z. 
Saline  Extraxtion of Kidney  ttomogenate.--SaUne-perfused kidneys were  obtained from 
large Osborne-Mendel rats. They were kept frozen until used. The kidneys were homogenized 
with an equal amount of saline in a Waring blendor for 3 minutes at 2°C. The homogenate 
was centrifuged at 65,900 G. for  1 hour, and the clear supernatant solution carefully drawn 
off and stored frozen. 
A bsorption of Antiserum by Supernatant Solution from A utolyzed or Trypsin-Digested Tissue 
Homogenates.--Up to 2.0 ml. of supernatant solution was mixed with the standard 1.5 ml. 
dose  of nephrotoxic serum, incubated 5 minutes at 37°C.,  and centrifuged at 2,000 R.P.~. 
The absorbed antiserum was then assayed for nephrotoxicity. A control (unabsorbed) anti- 
serum was assayed along with each group of absorbed sera.  For this purpose the standard 
1.$ ml. dose of pooled nephrotoxic serum (double the minimum amount necessary to produce 
proteinuria) was mixed with 2.0 ml. of normal saline. 
Trypsin: Armour tryptar ®: Each vial contained  about 91 rag. of whitepowder equivalent 
to 250 rag.  of activity of lyophilized  crystalline trypsin (250,000 units). Thus the 164 rag. 
used was equivalent to the activity of 450 rag. lyophilized crystalline trypsin (450,000 units). 
In further experiments one-quarter of this amount of trypsin appeared equally effective. HOWARD  C.  GOODMAN  AND  JAMES  H.  BAXTER  489 
Assay of Absorbed or Contrd Antiserum for Nephrotoxicity.--A 3.5 ml. sample of absorbed 
antiserum or control (unabsorbed)  antiserum diluted with saline was injected intravenously 
into a foot vein of each 150 gln. female Osborne-Mendel rat. The rats were placed in indi- 
vidual metabolism cages for overnight urine collection as described in the previous report (1). 
The protein content of the urine was measured  by the method of Shevky and  Stafford as 
described in reference 8 on the 1st,  2rid,  and 7th days following antiserum injection. 
RESULTS 
Absorption  of Nephrotoxic  Antibodies by Supernatant Solutions from Proteolytic 
Enzyme Digests or A utolysates of Tissue tIomogenates 
In addition to tryptic digestion and autolysis of kidney homogenate as described under 
Methods, rat lung, skeletal muscle, liver, and heart were each treated in precisely the same 
manner, and clear supematant solutions from tryptic digests and autolysates were obtained 
for testing. When no protective activity was detected in undiluted aliquots of the supematant 
solutions, the solutions were dialyzed overnight against distilled water at 2°C. and lyophilized 
in order to concentrate  any possible protective factor.  The lyophilized powder was  redis- 
solved in a volume of 0.15 M saline equivalent to one-fifth the original volunie of supernatant 
solution and  retested.  All preparations  were tested  for ability to absorb  nephrotoxic anti- 
bodies from pooled antiserum. 
The results of assays of the absorbed sera are tabulated in Table I. The head- 
ings below refer to this table. 
(a)  and  (b).--These are the results of control experiments from this and the previous re- 
port  (I). The normal 150 gin. female rats excreted 0.2  to 0.3  rag.  of protein per hour. The 
standard  dose of unabsorbed  antiserum  consistently produced kidney damage with average 
proteinuria of over 7 rag. per hour. 
(c)  Tryptic digestion of kidney homogenate produced a  high concentration of protective 
factor in soluble form, so that a volume of the supernatant solution (1.0 ml.) representing the 
extract of 0.5 gin. kidney homogenate completely neutralized the antibodies in the standard 
dose of nephrotoxic antiserum. These results were obtained consistently with the supernatant 
solutions from more than a  dozen individual tryptic digests of kidney homogenate. In most 
experiments the volume of superuatant  solution representing the extract of 0.25 gin. trypsin- 
digested kidney homogenate completely absorbed the nephrotoxic antibodies, although in one 
or two preparations this amount only partially protected against the nephrotoxic antibodies. 
In some experiments the amount of supernatant solution obtained from as little as 0.125 gm 
kidney completely neutralized the  standard  nephrotoxic dose of antiserum although in most 
preparations this amount o~y partially neutralized the nephrotoxic antibodies. Soluble pro- 
tective factor has also been obtained in  s a  few experiments after digestion of kidney with 
chymotrypsin or papain. 
(d) Tryptic digestion of lung homogenate released enough soluble protective factor so that 
the extract of 0.5  gin. digested lung homogenate gave protection. The concentrated super- 
natant  solutions,  representing  1.0  and  3.0  gin.  of lung homogenate,  also  neutralized  the 
nephrotoxic antibodies. 
(e) Tryptic digestion of homogenized skeletal muscle produced an easily detectable concen- 
tration  of soluble protective factor.  The volume of supernatant  solution representing 0.25 
gin. muscle homogenate only partially neutralized the nephrotoxic antibodies in the standard 
dose, while that representing the 0.5 gin. of muscle homogenate completely protected against 
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(f)  The  supernatant  solution from trypsin-digested heart  homogenate representing  1.0 
gin. of tissue only partially neutralized the nephrotoxic antibodies in the standard  dose of 
antiserum.  When the supernatant  solution was concentrated so that  the standard  dose of 
antiserum was absorbed with extract equivalent to 5.0 gin.  of trypsin-digested  heart  homo- 
genate,  complete neutralization of the nephrotoxic antibodies occurred. 
TABLE I 
E.~eas in Rats of Standard  Nephrotoxic  Serum after Absorption  against Extracts  of Trypsin 
Digested Rat Organ ttontogenates 
Standard 
nephrotoxic 
ser~ 
mr. 
(a)  0 
(b) i.5 
(c)  1.5 
1.5 
1.5 
(,~)  1.5 
1.5 
(e)  1.5 
1.5 
(f)  1.5 
1.5 
(g)  1.5 
1.5 
(h) 1.5 
1.5 
1.5 
1.5 
Semmabsorbed against: 
3.5 ml. saline (normal controls) 
2.0 mI. saline (nephrotoxic serum controls) 
Supernatant of trypsin digest of kidney 
Supernatant of trypsin digest of lung 
Concentrate of trypsin digest of lung 
Supernatant of trypsin digest of mnsde 
~t  tt  t¢  ~1  el  ct 
Supernatant of trypsin digest of heart 
Supernatant of trypsin digest of liver 
Concentrate of trypsin digest of Ii~er 
Supernatant of saline autolysate kidney 
cl  ~  ~t  t¢  ct 
Quantity 
of  tissue 
extracted 
0 
0 
0.25 
0.5 
1.0 
0.5 
1.0-3.0 
0.25 
0.5--1.0 
1.0 
5.0 
1.0 
5.0 
0.5 
1.0 
3.0 
5.0 
Proteinurla  produced 
by treated  antiserum 
O, Of 
~zts  "  Ist  2nd  7th 
day  day  day 
33  0.2  0.2  0.3 
63  7.8!  7.7  7.9 
15  1.7  [ 0.7  0.7 
20  0.3  I 02  0.3 
23  0.41  0.3  0.3 
3  0.9  0.4  0.3 
5  0.6  02  0.3 
5  2.8  3.7  3.2 
11  0.5  0.3  0.3 
17  3.6  1.9  1.5 
2  O.4  0.4  0.1 
10  5.0  6.0  9.0 
7  0.8  0.4  0.9 
6  3.6  4.6  2.5 
6  4.0  3.6  2.6 
1  0.50.g  02 
2  1.4  0.3  0.3 
Figures in italics are thought to indicate complete or almost complete protection. 
(g) Tryptic digestion of liver did not produce a detectable concentration of protective factor 
when unconcentrated aliquots of supernatant  fluid were tested. When the supernatant  solu- 
tion from tryptic digestion of liver was concentrated so that the antiserum dose was absorbed 
with extract equivalent to 5 gm. of the original tissue, the presence of protective factor ac- 
tivity could be detected. 
(h) When aliquots of the clear supernatant  fluid obtained by centrifuging the autolyzed 
kidney homogenate were tested, amounts obtained from 0.5 gin. and 1.0 gin. of kidney only 
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natant was concentrated by dialysis and lyophilization, amounts obtained from 3.0 and 5.0 
gin. kidney homogenate completely neutralized the nephrotoxic antibodies. The ability of the 
supernatant  solution from autolyzed kidney to absorb nephrotoxic antibodies seemed to be 
approximately the same as or slightly less than that of simple saline extract of kidney homo- 
genate  (1).  No  detectable  absorption  of nephrotoxic  antibodies occurred when the uncon- 
centrated supernatant  solutions from 1.0 gin. of autolyzed liver or muscle homogenates were 
tested. 
We have examined the possibility that  the protection against the effect of 
nephrotoxic antibodies might be due to the destruction of the antibodies by 
trypsin during the absorption of antiserum with the supernatant  solutions of 
trypsin digests. That this was not the case is indicated by the failure of uncon- 
centrated supernatant fluid from trypsin-digested liver homogenate to exhibit 
protective activity. In addition, trypsin inhibitor was added before the absorp- 
tion of the antiserum in a few experiments. And finally,  exhaustive  attempts 
were made to destroy the nephrotoxic antibodies with trypsin. Only after sev- 
eral hours incubation with even larger amounts of trypsin than  would have 
been present in these experiments could destruction of nephrotoxic antibodies 
be demonstrated.  Unless rat serum contains an inhibitor of trypsin activity, 
this would indicate that the portion of the antibody globulin molecule responsi- 
ble for the nephrotoxic effect is resistant to the proteolytic effect of trypsin. 
In addition to the ability of soluble protective factor to absorb nephrotoxic 
antibodies in vitro, the intravenous injection of supernatant solution of trypsin- 
digested kidney homogenate before the standard  dose of antiserum  afforded 
complete protection against nephrotoxic antibodies. In six rats, soluble protec- 
tive factor injected intravenously 10 minutes before the nephrotoxic antiserum 
completely neutralized  the effect of the nephrotoxic antibodies.  In five rats, 
soluble protective factor injected 30 minutes  before the antiserum  partially 
protected against the effect of the nephrotoxic antibodies. 
When  tested under  the present conditions,  0.25  gin.  of kidney homogenate 
successfully absorbed the nephrotoxic antibodies in the standard  dose of 1.5 
ml. pooled antiserum (1). For the purpose of the present study, we have defined 
that  amount of the antigen  or antigen  derivative (soluble  protective factor) 
which  completely protects against  the standard  1.5 ml.  dose of nephrotoxic 
antiserum  as  one  protective  unit.  Whether  the  soluble protective  factor  is 
whole antigen or a hapten-like derivative will be discussed.  From Table I and 
data in the previous report (1) we can make the following approximations re- 
garding  organ  content and extract content of antigen  or antigen  derivative: 
Whole kidney homogenate contains 1 protective unit/0.25 gin. of tissue.  Saline 
extract or autolysate of kidney contains 1 protective unit/1.O to 2.0 gln. of tissue 
extracted. Trypsin digest supernatant of kidney contains 1 protective unit/0.25 
gin. of tissue extracted. Trypsin digest supernatant of lung and muscle contains 1 
protective unit/0.5  gin.  tissue extracted.  Trypsin digest supernatant o] heart 
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Characterization of Soluble Protective Factor Obtained by  Tryptic  Digestion of 
Kidney tIomogenate 
Stability: 
The data in Table II show that the factor survived heating at 60°C. for as 
long as 2 hours, but was destroyed by heating to 80  ° for 30 minutes or 100°C. 
for 2 minutes. It was non-dialyzable and could be lyophilized and stored indefi- 
nitely in the frozen state without appreciable  loss of activity. 
Precipitation by Ammonium Sulfate: 
Material containing protective activity could be precipitated by ammonium 
sulfate from the supernatant solution of tryptic digests of kidney homogenate. 
TABLE  II 
Effect  in  Rats  of Standard  Nephrotoxic  Serum  after  Absorption  against  Heated  Extracts  of 
Trypsin-Digested  Rat Kidney Homogenates 
Standard 
nephro- 
toxic 
serul~ 
ml, 
1.5 
1.5 
1.5 
1.5 
1.5 
Serum absorbed  against: 
Supernate of trypsin digest 
Quanti| 
of kldn 
1.0 
1.0 
1.0 
1.0 
1.0 
Conditions 
60°C.  -  30 min. 
60°C,  -  60  " 
60oc._120  ,, 
80°C.  -  30  " 
100°C.  -  2  " 
No. 
of 
rats 
3 
2 
2 
3 
4 
Proteinuria produced 
by treated antiserum 
ist  2nd  7th 
day  day  day 
rig.~  rag.~  m~./ 
hr.  hr.  hr. 
3.4  0.2  0.2 
~).8  0.2  0.4 
3.6  0.1  0.4 
3.6  6.2  6.5 
7.8  8.8  9.2 
All precipitations were done at room temperature. The precipitate was washed 
once with the appropriate concentration of ammonium sulfate, dialyzed over- 
night against distilled water at 2°C., and tested for ability to absorb nephrotoxie 
antibodies. 
Table III shows the protective factor activity present in eleven preparations 
of supernatant solution from tryptic digestion of kidney homogenate, and the 
protective factor activity recovered in the precipitates formed by increasing the 
ammonium sulfate concentration to the levels shown. 
Large variations in degree of recovery of activity occurred. 
The use of the bioassay, although strictly standardized,  plus an inexplicable loss of the 
protective factor activity in certain instances, resulted in recovery in the ammonium sulfate 
precipitates of as little as 20 per cent of the initial protective factor activity in some experi- 
ments and as much as 100 per cent of the activity in others. No protective factor activity was 
present in material precipitated  by 30 per cent saturation with ammonium sulfate when as 
little as 10 per cent of the original activity would have been detectable under the conditions of 
the experiment. 15 per cent of the initial protective factor activity (from I0 to 25 per cent in HOWARD  C.  GOODMAN  AND  JAMES  H.  BAXTER  493 
individual  experiments) was found in the 1.75 M (0.5 saturated) ammonium sulfate precipitate,  s 
51 per cent of the original activity (20 to 100 per cent in individual experiments) was pre- 
cipitated between 1.75 M and 2.68 M (0.67 saturated) ammonium sulfate• In a final experiment 
(M6) when 464 protective units were presented initially, 5 per cent was detected in the super- 
natant of the 2.68~ ammonium sulfate fractionation. Some purification was achieved by the 
fractionations; the lower half of the table shows the protective factor activity related to pro- 
rein content in the ammonium sulfate precipitates obtained in the experiments listed in the 
columns directly above the figures.  The most active preparation, the 2.68 ~r precipitate of 
Experiment M-6, contained over 15 protective units/rag, protein compared to 2 protective 
TABLE III 
Units of Protective Factor Activity Present in Ammoniun Sulfate Precipitates of Extracts of 
Trypsin Digested Rat Kidney Homogenated: Results Obtained in 
Eleven Individual  Ex ~eriments 
Preparation 
~ssayed 
trypsin  digest  superna- 
tant  (whole) 
).3 sat. (NH4)tSO~ precipi- 
tate 
1.75 ~  (0,5 sat.) precipitate 
!•68 M (0.67 sat.)  precipi- 
tate 
L68 M (0.67  sat•) superna- 
tant 
10  10 
!(<2)  (<2) 
(<2) (<2) 
2  2 
(<2) 
10 
(<2) 
2 
(<2) 
20 
(<2) 
50  50 
(<51  -- 
5  5 
33  13 
(<Sl (<5) 
10 
(<2) 
s 
(<2) 
10 
i0 
(<2) 
20  20 
5  5 
15  13 
(<5) (<5) 
464 
40 
240 
20 
Amount o 
original  No. rat! 
activity  used in 
recovered, assay 
average 
per cent 
--  6 
15  27 
51  58 
4  22 
Protective Units Activity per rag. Protein in above Experiments 
Sz  M1  M2  M3  M4  M6  Average 
[. 
0.4  1.2  1.0  0.5  2  1.0 
0.33  0.3  0.4  0.5  0.4 
1•6  0•5  14  2.0-4-  2.0  15,6  6.0 
0•5  0.5 
trypsin digest  supernatant 
t.Ts it (0.5  sat.)  precipitate 
L68 ~  (0.67  sat.)  precipitate 
L68 M (0.67  sat.)  supematant 
traits/rag, protein in the initial trypsin digest  supernatant solution. The average increase in 
protective activity per mg. of protein in the 2.68 ~t precipitate was sixfold. 
In the purest preparation obtained so far,  an amount containing 0.064 rag. 
protein contained enough soluble protective factor  to  absorb the nephrotoxic 
antibodies from the standard dose of 1.5 ml. of antiserum. 
Elearoptwretic Pattern: 
In Experiment M-6, the 2.68 ~  ammonium sulfate precipitate obtained from 116 ml. of 
supernatant of trypsin digest  of kidney homogenate (containing 4 protective units/ml.) was 
Note that the 0.5 saturated ammonium sulfate preparations (Exp. Sr-S~, Table IH) are 
not exactly equivalent to the 1.75 ~  preparations (Exp. MFMs), 0.5 saturated ammonium 
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dialyzed overnight at 2"C. against barbital buffer, pH 8.6. The precipitate went into solution 
except for a faint flocculent haze, and this was removed by centriingation  so that a clear tea- 
colored solution was prepared for electrophoresis.  Electrophoresis was performed in an Aminco 
model B electrophoresis  apparatus  4 at pH 8.6 and ionic strength 0.1. A small fast peak with a 
mobility of 13 X  10  --6 cm.2/volt sec. anda large skewed slow peak witha mobility  of about 4 X 
10  "~ cm.2/volt see. were seen. The electrophoresis was continued  until the fast component had 
run off the viewing screen and then 1.0 ml. of the ascending limb solution was aspirated to 
obtain a sample of the fast component, and 1.0 ml. of the descending limb was aspirated to 
obtain a sample of the slow component. 
Assay of the  two  components showed  definite protective  factor  activity in 
the slow component, but none at all in the fast component. An absorption peak 
at  260 m#.  suggested  that  the  latter  contained nucleic  acid.  It  was  obvious 
that the slow component containing protective activity was not a  homogenous 
peak  in the  Tiselius pattern;  undoubtedly it  was  a  mixture  of  proteins  and 
perhaps other substances. 
Digestion  of Soluble Protective Factor with Enzymes: 
Proteolytic Enzymes.--Results of incubation of protective factor with proteo- 
lytic enzymes at 37°C. and appropriate pH are shown in Table IV.  Headings 
below refer to the table. 
(a) Incubation with 5.0 rag. Trypsin or Chymotrypsin.--2.0 ml. of trypsin digest supernatant 
solution contained 2 protective units (enough protective factor to absorb nephrotoxicity from 
two standard 1.5 ml. doses of antiserum). The 2.0 ml. aliquot contained about 4.0 rag. of pro- 
tein. Incubation of the solution containing 2 protective units at pH 8.5, 37°C. for 3 hours with 
5.0 rag. trypsin or chymotrypsin did not produce detectable (over 50 per cent) destruction of 
protective factor. This was true even when a  second 3 hour period of incubation with an 
additional 5.0 mg. of trypsin followed  the initial one.  Further experiments were therefore 
performed using larger amounts of trypsin, chymotrypsin, papain, and pancreatin. 
(b) Incubation with Larger Amounts of Enzymes.--l.5 ml. trypsin digest superuatant solu- 
tion contained approximately 3.0 rag. of protein and 1.5 protective units (enough protective 
factor to neutralize 1.5 standard doses of antiserum). When the solution containing this much 
protective factor was incubated for 3 hours at 37"C., pH 8.5, with 20 rag. trypsin and then for 
an  additional 3  hours  with  20  rag.  chymotrypsin, some  destruction of protective factor 
occurred.  The same effect was obtained by incubating initially with 20 mg.  chymotrypsin 
followed by a second 3 hour incubation period with the additional 20  rag. chymotrypsin. In 
five preparations no detectable destruction occurred when 20 rag. trypsin was used in each of 
the two incubation periods,  although in a sixth such preparation not listed in the table some 
apparent destruction of protective factor occurred.  While protective factor without added 
enzymes was usually stable during the incubation  period at pH 8.0 to 8.5, in two out of twelve 
experiments some activity was lost in this procedure.  This is probably the explanation for the 
apparent destruction of protective factor in one of the six double digestions with 20 mg. 
trypsin. 
If the double incubation with trypsin-chymotrypsin was attempted using 2.5 protective 
units, instead of 1.5 protective units, enough protective factor activity remained to absorb 
almost completely the nephrotoxic antibodies in a standard dose of nephrotoxic serum; i.e., 
4 This analysis was performed by Dr. Robert S. Gordon, Jr. HOWARD  C.  GOODMAN  AND  JAMES  H.  BAXTER  495 
approximately 40 per cent of the original activity was stili present. Presumably then, not much 
more than 50 per cent destruction of protective factor occurred even with the double incuba- 
tion with amounts of trypsin or trypsin plus chymotrypsin many times larger than the amount 
of protein in the protective factor solution. 
(c) Neither papain nor pancreatin produced any detectable destruction of protective factor 
under the conditions described. 
TABLE IV 
Effects in Rats of Standard Nephrotoxic Serum after Absorption witk Protective  Factor Treated 
with Proteolyti~ Enzymes 
Protelnuria produced 
Standard  Protective  Enzyme treatment of protective  No. of  byabsorbedantiserun 
nephrotoxic  factor  factor before absorption  rats 
serum  1st  2nd  7th 
day  day  day 
mL  mL TDS*  mg./hr, mg./hr, :mg./hr 
(a)  1.5  +  2.0  +  Trypsin 5 mg.  -- 3 hrs.~  +  trypsin  2  --  0.2  0.2 
5 rag.  -- 3 hrs.:~ 
1.5  +  2.0  +  Trypsin 5 rag.  -  3 hrs.~  2  --  0.7  0.8 
1.5  +  2.0  +Chymotrypsin5mg,-3hrs.  6  0.7  0.3  0.1 
Ib)  1.5  +  1.5  +  Trypsin 20rag.  -  hrs.  +  chymo-  4  3.6  2.5  1.0 
trypsin 20 rag.  -  3 hrs. 
1.5  +  1.5  +  Chymotrypsin20mg.  -  3hrs.  +  4  3.3  1.5  1.1 
chymotrypsin 20 rag.  -  3 hrs. 
1.5  +  1.5  +Trypsin20mg.  -3hrs.+trypsin  5  0.5  0.5  0.2 
20 rag.  -- 3 hrs. 
1.5  +  2.5  +Trypsin20mg.  -  3hrs.  +chymo-  4  1.5  0.8  0.6 
trypsin 20 mg.  -  3 hrs. 
~c)  1.5  +  1.5  +  12.5-25.0mg.  papain§  -  3 hrs.  4  0.5  0.3  0.3 
1.5  +  2.5  +  25 rag. papain§  -  6hrs.  2  0.4  0.2  0.3 
1.5  +  2.5  +  25  "  pancreatin§  -  6hrs.  2  0.5  0.2  -- 
1.5  +  1.5  +  50  "  pancreatin§  -  3 hrs.  1  0.4  0.2  0.3 
Figures in italics show protection, or failure to destroy protective factor. 
* Supernatant fluid from trypsin digestion of kidney as described in text. 
5 rag.  trypsin inhibitor added after digestion. 
§ These enzymes were crude preparations. 
Other  Enzymes.--No  detectable  destruction  of protective  activity occurred 
when  solutions  of protective  factor  were incubated  under  appropriate  condi- 
tions  with  hyaluronidase,  /3-glucuronidase,  pectinase,  lysozyme,  a-amylase, 
or amylopsin. 
Antigenicity of the Kidney Extracts: 
Four rabbits were injected intraperitoneally with the simple saline extract of rat kidneys, 
and  4  rabbits  were injected intraperitoneally  with  the  supernatant  solution  from  tryptic 
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equivalent protective activity were prepared for each injection (4 protective units per injec- 
tion of trypsin digest  supernatant  solution and  3  protective units  per injection of simple 
saline  extract).  The  eight  rabbits  were injected intraperitoneally  twice weekly with  each 
substance for 3 weeks and then bled by heart puncture 10 days after the last injection. This 
procedure was repeated 3 times. One rabbit receiving tryptic digest supernatant solution died 
after the first bleeding; the serum contained no nephrotoxic antibodies at  that  time. This 
result is not included in Table V. In addition, 4 rabbits received a single intramuscular injec- 
tion of lyophilized saline extract (containing 60 protective units of antigen) in Freund's adju- 
vant  and  4  rabbits  received  a  single  intramuscular injection of lyophilized trypsin digest 
supernatant  (containing 48 protective factor units)  in Freund's adjuvant. They were bled 3 
weeks later and the sera assayed for nephrotoxicity. The sera were tested as described under 
Methods regarding assay of absorbed or control antiserum for nephrotoxicity. If 1.5  ml.  of 
rabbit serum diluted to 3.5 ml. with saline was ineffective in producing proteinuria in the assay 
TABLE V 
Immuni~.ation Experiments: The No. of Rabbits Which Developed Nephrotoxic Antibodies When 
Immunized  with Saline  Extract or Trypsin Digest Supernatant  of Rat Kidney tIomogenate 
Rabbits immunized with: 
Saline extract kidney 
(i.p.  2 x wk.) 
Tryp. dig. supt. kidney 
(i.p.  2 x wk.) 
Saline extract kidney 
(Single injection in fr. adj.) 
Tryp. dig. supt. kidney 
(Single injection in fr. adj.) 
No. of 
rabbits 
No. of rabbits with sera producing proteinuria 
of various magnitudes 
Prote~nurla in 
assay rat 
Proteinuria in 
a~ay rat 
No 
protein- 
>  1 reg./hr, on  uriaoftet 
multiple injection  f 
mjecfiom 
>5  1-5 
reg./hr,  reg./hr. 
2  2 
2 
injections 
3 
injections 
rat, 2.0 ml. of the rabbit serum was assayed. If again no proteinuria was produced, 1.S ml. of 
the rabbit serum (diluted to 3.5 ml. with saline)  was injected intravenously into an assay rat 
on 3 consecutive days. 
The results listed in Table V show the number of rabbits which developed nephrotoxic anti- 
bodies. Each rabbit is listed in the column showing the degree of proteinuria produced by the 
s'mgle most potent nephrotoxic serum obtained. All 8 rabbits immunized with simple saline 
extract of kidney developed detectable nephrotoxic antibodies.  One of 3  rabbits  receiving 
intermittent intraperitoneal injections of the superaatant fluid from tryptic digestion of kidney 
homogenate developed nephrotoxic serum, but with a low titer only detectable after the assay 
rat received 3 consecutive daily injections of 1.5 ml. of rabbit serum. None of the 4 rabbits 
which received the single intramuscular injection of concentrated soluble protective factor in 
Freund's adjuvant developed a detectable titer of nephrotoxic antibodies. 
These  results  indicate  that  the  saline  extract  contains  the  whole  antigen, 
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nephrotoxic antibodies when injected into rabbits. The soluble protective factor 
in trypsin digest supernatant  solution, however, while retaining  its ability to 
absorb nephrotoxic antibodies from antiserum,  is either no longer antigenic or 
at most only slightly antigenic. 
DISCUSSION 
Tryptic digestion of kidney homogenate  produces  relatively high concentra- 
tions of a soluble protective  factor. The term protective  factor is used because 
the trypsin digest supernatant solution can absorb nephrotoxic  antibodies  from 
antiserum but it is not itself antigenic  to any appreciable extent; i.e., immuni- 
zation of seven rabbits with the supernatant solution from tryptic digestion 
of kidney homogenate  produced  nephrotoxic  antiserum in only  one animal. It 
is difficult to  evaluate the  one weakly nephtotoxic antiserum produced in 
immunizing with the trypsin-digested  soluble protective factor. It is possible 
that some whole antigen survived the proteolytic  enzyme  action and that this 
might be destroyed  by more prolonged  digestion. 
Landsteiner proposed the term hapten for non-protein substances which, 
although active in vitro (i.e. in precipitin reactions)  "often induced no or only 
slight antibody response"  (9).  The protective factor is presumably a  portion 
of the whole antigen which still retains the property of combining with nephro- 
toxic antibodies although  it is no longer,  or at most only slightly,  antigenic. 
Initial  studies  on  the  nature  of this  protective  factor  or  antigen  derivative 
show that  in some ways it resembles a  protein,  and  in other ways does not. 
Like some proteins,  it  is stable  at  60°C.  but destroyed by 80°C.;  it  is non- 
dialyzable  and  can be precipitated  fairly specifically with  certain  concentra- 
tions of ammonium sulfate. On the other hand, it is not fully antigenic,  nor is 
it  destroyed by proteolytic  enzymes  except under  conditions  which  make  it 
questionable that the destruction is specifically due to enzyme proteolysis. The 
purest preparation  of protective factor so far obtained,  with an activity of  1 
protective  unit/0.06  rag.  protein,  is  undoubtedly  contaminated  with  other 
substances. We are attempting further purification before interpreting analyses 
of this  preparation.  Preliminary  studies on the purest  preparations  obtained 
thus far indicate  that hexosamine is present and  that  localized Schwartzman 
reactions are produced in rabbits. If these characteristics are actually those of 
the protective factor rather  than  those of contaminating  substances,  we may 
be dealing  with a  carbohydrate-containing  moiety,  split off from the original 
whole antigen,  and  the  term  hapten  may  be applied  to  the  soluble  antigen 
product. 
In  view of the  concept  that  the  antigen  responsible for  the production  of 
nephrotoxic antibodies is present in organs other than  the kidney (1, 10), it is 
of interest that the unconcentrated  supernatant  fluid from tryptic digestion of 
lung and skeletal muscle yields soluble protective factor in amounts only slightly 
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supernatant  solution from tryptic digestion of heart and liver homogenates, 
protective factor can be detected. These results are consistent with the studies 
describing  the wide distribution of nephrotoxic antigen reported in the previous 
paper (1). 
The significance for human disease states of these studies on an antigen and 
antigen derivative present in rat tissues is a matter for conjecture at present. 
One hypothesis for the pathogenesis of glomerular  nephritis and the nephrotie 
syndrome  postulates  the  production  of  antibodies  against  kidney antigens. 
Such antibodies against a saline extract of human kidney in nephritis has been 
reported (11). The rat tissue antigen present in the kidney which is responsible 
for the production of nephrotoxic antibodies when injected into rabbits may 
differ from a kidney tissue antigen responsible for the production of autoanti- 
bodies.  We  are  preparing  to  determine  whether  patients  with  glomerular 
nephritis and nephrotic syndrome show evidence of hypersensitivity to a soluble 
substance derived from saline extraction and tryptic digestion of human kidney 
homogenates. 
The problem of homotransplantation  of kidneys offers another application 
for studies with a soluble tissue antigen or hapten.  In the dog,  the failure of 
kidney homotransplants seems to be due to an immune response on the part of 
the recipient to an antigen or antigens present in the donor kidney. We are 
using  saline extracts and trypsin digest extracts of donor dog kidney homoge- 
nate to test for the development of antibodies to donor kidney in the serum 
of the dog receiving  a kidney homotransplant,  and to determine whether ad- 
ministration of such extracts will affect the time of survival of the homotrans- 
planted kidney. 
SUMMARY 
A  soluble protective  factor,  capable  of  absorbing  nephrotoxic  antibodies 
from anti-rat kidney serum,  can be obtained in high concentration by tryptic 
digestion of rat kidney homogenate. The factor is no longer antigenic or at most 
only slightly so. It is stable at 60  °, destroyed by boiling, is non-dialyzable,  can 
be precipitated by ammonium  sulfate, but resists destruction by proteolytic 
and other enzymes.  In accord with previous studies on the organ localization 
of the rat  tissue antigen responsible for the production of nephrotoxic anti- 
bodies, the soluble protective factor, or antigen derivative, can be obtained by 
tryptic digestion of rat lung,  skeletal muscle, heart, and liver. 
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